Evidence map›Paper›PMID 40810797›Full record

ArticleNaunyn-Schmiedeberg's archives of pharmacology2026

Global research hotspots, trends, and future directions of ivermectin research: an informatics investigation (2020-2025).

Siddig Ibrahim Abdelwahab, Manal Mohamed Elhassan Taha, Khaled A Sahli, Moath Mohamed Farasani, Marwa Qadri, Abdulaziz Alarifi, Amani Khardali, Khloud H Alsaadi, Abdullah Farasani, Nizar A Khamjan and 3 more

Abstract read
PubMed Publisher
In one paragraph

Article in Naunyn-Schmiedeberg's archives of pharmacology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Siddig Ibrahim AbdelwahabHealth Research Centre, Jazan University, 45142, Jazan, Saudi Arabia. sadiqa@jazanu.edu.sa.
Manal Mohamed Elhassan TahaHealth Research Centre, Jazan University, 45142, Jazan, Saudi Arabia.
Khaled A SahliSecurity Forces Hospitals Program, General Directorate of Medical Services, Ministry of Interior, Riyadh, Saudi Arabia.
Moath Mohamed FarasaniKingdom of Saudi Arabia, Prince Mohamed Bin Naser Hospital Jazan, Jazan, Kingdom of Saudi Arabia.
Marwa QadriDepartment of Pharmacology and Toxicology, College of Pharmacy, Jazan University, 45142, Jazan, Saudi Arabia.
Abdulaziz AlarifiDepartment of Basic Sciences, College of Science and Health Professions, King Saud Bin Abdulaziz University for Health Sciences, Riyadh, Saudi Arabia.
Amani KhardaliDepartment of Clinical Pharmacy, College of Pharmacy, Jazan University, 45142, Jazan, Saudi Arabia.
Khloud H AlsaadiDepartment of Biological Sciences, Jeddah University, Jeddah, Saudi Arabia.
Abdullah FarasaniHealth Research Centre, Jazan University, 45142, Jazan, Saudi Arabia.
Nizar A KhamjanDepartment of Medical Laboratory Technology, Faculty of Nursing and Health Sciences, Jazan University, Jazan, Saudi Arabia.
Jobran M MoshiHealth Research Centre, Jazan University, 45142, Jazan, Saudi Arabia.
Saeed AlshahraniDepartment of Pharmacology and Toxicology, College of Pharmacy, Jazan University, 45142, Jazan, Saudi Arabia.
Ahmad AssiriDepartment of Dermatology, Faculty of Medicine, Jazan University, Jazan, Saudi Arabia.

Funding

Jazan University JU- 20250296 -DGSSR- RP -2025
6 · The paper itself

Abstract

Ivermectin, a widely used antiparasitic drug, gained global attention during the COVID-19 pandemic for its proposed antiviral effects. This study explores how ivermectin research evolved between 2020 and 2025, identifying key trends, emerging topics, and thematic changes. A data-driven bibliometric and informatics-based analysis was conducted using the Scopus database. Original articles were examined through advanced co-citation, co-word, and bibliographic coupling techniques. We employed artificial intelligence-enabled clustering algorithms, including Walktrap and hierarchical models, using tools such as VOSviewer and Bibliometrix (R package), to explore the conceptual landscape and research dynamics. A total of 1,041 ivermectin-related articles were included. Research topics shifted from antiparasitic and veterinary uses to newer areas like COVID-19 treatment, drug repurposing, oxidative stress, and vector control. We identified 12 thematic clusters and six co-word clusters. Although citation impact declined after 2021, interest remained strong in molecular and pharmacological mechanisms. Key authors, journals, and studies were also identified. This is the first AI-enhanced bibliometric mapping of ivermectin literature in the post-pandemic era. The findings uncover underexplored but promising research directions-such as apoptosis, immunomodulation, and nanodelivery-and highlight the added value of machine learning tools in uncovering complex thematic transitions and research frontiers. This approach offers deeper insights than traditional bibliometric methods by uncovering nuanced thematic transitions through AI-powered clustering.

Indexed as

Antiparasitic AgentsBiomedical ResearchCOVID-19 Drug TreatmentIvermectinAnimalsAntiviral AgentsBibliometricsHumansAntiparasitic AgentsAntiviral AgentsIvermectinCOVID-19Drug repurposingInformaticsIvermectinVector control

Identifiers

PMID40810797

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.